Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine for CINV in testicular cancer patients on 5-day cisplatin
NCT05244577Phase 3Unknown
- Start
- Jan 2022
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of olanzapine in chemotherapy-induced nausea and vomiting (CINV). Status: unknown.
02
Drugs
olanzapine
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT05244577.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05244577.